WhiteLab Genomics vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-08-23
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionWhiteLab GenomicsIsomorphic Labs
PricingContactContact
Target UserGene therapy researchers, biotech/pharma, academic labsLarge pharma companies, big pharma partnerships
Core TechnologyAI-predicted AAV capsid design, promoter optimization, guide RNA designAlphaFold-based protein-ligand predictive models, generative molecule design
Delivery FocusAAV, LV, non-viral delivery optimizationNot specified (small molecule/biological drug design)
Partnership ModelCollaborations with Sanofi, Cytiva, DebiopharmExclusive large-scale pharma partnerships (Novartis, J&J)
Latest NewsNo recent newsSeries B (2026), $600M investment (2025), J&J collaboration (2026)

If you need AI-guided design for gene therapy constructs (capsids, promoters, guides) with in silico validation and collaborative workspaces, WhiteLab Genomics is the targeted choice. For large-scale small molecule drug discovery powered by AlphaFold and deep pharma partnerships, Isomorphic Labs is the more powerful but less accessible platform. Choose based on whether your focus is genomic medicine or traditional small molecule drug development.

WhiteLab Genomics
WhiteLab Genomics

AI-driven platform to design genomic medicine constructs with validated in vivo CNS delivery

Visit Website
Isomorphic Labs
Isomorphic Labs

AI-first drug discovery partner built on Nobel-winning AlphaFold.

Visit Website
Pricing
Contact Sales
Contact Sales
Plans
Popularity
4 views
7.4k views
Skill Level
Advanced
Advanced
API Available
Platforms
Web
Categories
🧬 Drug Discovery & Life Sciences
🧬 Drug Discovery & Life Sciences
Features
AI-predicted AAV capsid design with novel tropisms
Promoter optimization for cell-type specificity
Guide RNA design for CRISPR-based therapies
Toxicity prediction for molecular constructs
Delivery vehicle optimization (AAV, LV, non-viral)
Collaborative project workspaces
Access to proprietary biological datasets
In silico construct validation before synthesis
Off-target prediction for gene editing
Target receptor identification for viral vectors
Payload design for gene therapies
Bioproduction optimization for AAV and LV
Cell therapy (CAR design) support
Multi-modal design (AAV, lentivirus, nanoparticles)
In vivo data demonstrated targeted brain delivery after IV injection
Built on Nobel-winning AlphaFold system
Generative AI molecule design via Drug Design Engine
Predictive AI models for protein-ligand interactions
Digital biology simulation at scale
End-to-end drug discovery from target ID to lead optimization
Partnership model with Novartis and Johnson & Johnson
Drug metabolism and toxicity simulation
Bioresilience framework for pandemic preparedness
US operations established in 2025
Series B funding in February 2026
Max Jaderberg appointed as President
Dr. Ben Wolf appointed as Chief Medical Officer
Interdisciplinary team of ML and drug discovery experts

What real users say: WhiteLab Genomics vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

WhiteLab Genomics

5 mentions across 1 sources · 50% positive — mixed

YouTube

What users praise

  • AI-driven design for AAV capsids, promoters, and guide RNAs improves accuracy.
  • Partnerships with Sanofi, Cytiva, and Debiopharm validate technology.
  • Covers multiple modalities: AAV, lentivirus, and nanoparticles.
  • In vivo brain delivery demonstration is a significant milestone.

What frustrates them

  • Lack of independent user reviews undermines trust and assessment.
  • No transparent pricing; requires contact, which may deter small labs.
  • Advanced skill level needed; not accessible to beginners.
  • No mention of integrations or API, limiting workflow flexibility.

Researched Aug 4, 2026

Isomorphic Labs

48 mentions across 3 sources · 82% positive

Hacker News, YouTube, Lemmy

What users praise

  • Built on the Nobel-winning AlphaFold, giving it instant credibility in structural biology.
  • Drug Design Engine extends beyond structure to generative molecule design, promising novel chemistry.
  • Deep partnerships with Novartis and J&J, with potential billions in royalties.
  • Interdisciplinary team of top ML and drug discovery experts, ensuring depth of expertise.

What frustrates them

  • Not accessible to individual researchers or small biotech due to partnership model only.
  • Proprietary nature of parts of its tech limits community scrutiny and independent validation.
  • CASP16 results suggest AlphaFold 3-based models aren't always better than older methods for protein-ligand interactions.
  • No marketed drugs yet; outcomes remain uncertain with royalties tied to long timelines.

Researched Aug 18, 2026

Who should pick which

  • Gene therapy startup optimizing AAV capsids
    Pick: WhiteLab Genomics

    AI-predicted capsid design and promoter optimization are core to its platform; features directly address AAV engineering.

  • Large pharma with multi-billion dollar drug pipeline
    Pick: Isomorphic Labs

    Partnership model and AlphaFold-based predictive power fit large-scale, resource-intensive programs; J&J collaboration validates this.

  • Academic lab studying CRISPR therapies
    Pick: WhiteLab Genomics

    Provides guide RNA design, off-target prediction, and in silico validation—essential for academic gene editing research.

  • CRO offering nucleic acid therapy validation
    Pick: WhiteLab Genomics

    Collaborative workspaces and integration with lab data formats support CRO workflows for gene therapy validation.

Frequently Asked Questions

WhiteLab Genomics vs Isomorphic Labs: which should you choose?

If you need AI-guided design for gene therapy constructs (capsids, promoters, guides) with in silico validation and collaborative workspaces, WhiteLab Genomics is the targeted choice. For large-scale small molecule drug discovery powered by AlphaFold and deep pharma partnerships, Isomorphic Labs is the more powerful but less accessible platform. Choose based on whether your focus is genomic medicine or traditional small molecule drug development.

Which platform is better for designing AAV capsids?

WhiteLab Genomics offers AI-predicted AAV capsid design with novel tropisms; Isomorphic Labs does not offer this feature.

Can I use Isomorphic Labs for CRISPR guide RNA design?

No. Isomorphic Labs focuses on small molecule drug discovery, not gene editing tools.

Which tool is more affordable?

Both use contact-based pricing. WhiteLab may have lower entry barriers for smaller teams, while Isomorphic targets large pharma partnerships with significant investment.

Does WhiteLab Genomics support non-viral delivery?

Yes, it includes delivery vehicle optimization for AAV, LV, and non-viral methods.

Is Isomorphic Labs based on AlphaFold?

Yes. Isomorphic Labs was spun out of DeepMind and uses AlphaFold as a foundation for protein-ligand interaction predictions.

Which platform has public partnerships?

WhiteLab partnered with Sanofi, Cytiva, Debiopharm. Isomorphic partnered with Novartis and Johnson & Johnson (2026).

Can I get a free trial for either platform?

No. Both require contacting sales; no public self-service tiers.

Which platform is better for AI drug discovery collaboration?

Isomorphic Labs is structured for deep pharma collaborations; WhiteLab Genomics also supports collaborative workspaces but is more product-oriented.

More WhiteLab Genomics or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026